section name header

Basics ⬇

DESCRIPTION

Obstruction to LV outflow

EPIDEMIOLOGY

Incidence

Prevalence

RISK FACTORS

GENERAL PREVENTION

A large prospective randomized clinical trial, Simvastatin and Ezetimide in Aortic Stenosis (SEAS), failed to demonstrate overall benefit or prevention of stenosis progression in patients with mild to moderate aortic stenosis treated with intensive lipid-lowering therapy. Although atherosclerotic risk factors are associated with aortic valve calcification, further study is needed before pharmacologic therapy can be recommended.

PATHOPHYSIOLOGY

ETIOLOGY

COMMONLY ASSOCIATED CONDITIONS

Diagnosis ⬆ ⬇

History

Physical Exam

DIAGNOSTIC TESTS & INTERPRETATION

Lab

Imaging

DIFFERENTIAL DIAGNOSIS

Medication (Drugs) ⬆ ⬇

Treatment ⬆ ⬇

ADDITIONAL TREATMENT

General Measures

Referral

Patients should be referred to a cardiologist for initial assessment when AS is diagnosed as moderate to severe, or if associated symptoms are present.

SURGERY

Ongoing Care ⬆ ⬇

FOLLOW-UP RECOMMENDATIONS

Patient Monitoring

PATIENT EDUCATION

PROGNOSIS

COMPLICATIONS

Miscellaneous ⬆ ⬇

CODES

ICD9

424.1 Aortic valve disorders

SNOMED

60573004 aortic valve stenosis (disorder)

Reference(s) ⬆ ⬇

ADDITIONAL READING

Author(s) ⬆

Linda A. Pape